Astrantus’s Oracle ORCL Stock Holding History

Astrantus’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,869	Closed	-$337K	–	270
2021 Q4	$337K	Buy	+3,869	New	+$363K	0.25%	156

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Astrantus's ORCL Position: Q1 2022 in Review

Astrantus sold out of Oracle (ORCL) in Q1 2022, closing a stake of 3,869 shares — an estimated $337K sold.

Astrantus first reported a position in ORCL in Q4 2021 and held it in 1 quarter. The position peaked at $337K in Q4 2021. 2,266 funds tracked by Wall St. Rank hold ORCL as of Q1 2022.

Astrantus reported no remaining Oracle position as of Q1 2022 after selling out during the quarter.
Astrantus sold 3,869 Oracle shares in Q1 2022, an estimated $337K.
Astrantus first reported a position in Oracle in Q4 2021 and held it in 1 quarter.
Astrantus's Oracle position peaked at $337K in Q4 2021.
2,266 funds tracked by Wall St. Rank held Oracle as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.